Ya‐ting Liu & Shang‐shang Wang. (2023). Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination. Wiley.
Chicago Style (17th ed.) CitationYa‐ting Liu and Shang‐shang Wang. Ixekizumab Successfully Treated Severe Pityriasis Rubra Pilaris After COVID‐19 Vaccination. Wiley, 2023.
MLA (9th ed.) CitationYa‐ting Liu and Shang‐shang Wang. Ixekizumab Successfully Treated Severe Pityriasis Rubra Pilaris After COVID‐19 Vaccination. Wiley, 2023.
Warning: These citations may not always be 100% accurate.